239 related articles for article (PubMed ID: 36012417)
21. Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs.
Harsanyi S; Novakova ZV; Bevizova K; Danisovic L; Ziaran S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361996
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Value of Combination of MicroRNA-192 in Urinary Sediment and B-Ultrasound for Bladder Cancer.
Jiang F; Li C; Han J; Wang L
Technol Cancer Res Treat; 2020; 19():1533033819894573. PubMed ID: 32106776
[TBL] [Abstract][Full Text] [Related]
23. Comet-FISH analysis of urothelial cells. A screening opportunity for bladder cancer?
La Maestra S; Benvenuti M; D'Agostini F; Micale RT
Expert Rev Mol Diagn; 2023; 23(8):653-663. PubMed ID: 37334662
[TBL] [Abstract][Full Text] [Related]
24. [Liquid biopsy to indvidualise therapy in advanced bladder cancer].
Junker K
Aktuelle Urol; 2022 Apr; 53(2):180-187. PubMed ID: 34875700
[TBL] [Abstract][Full Text] [Related]
25. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.
Kumar P; Nandi S; Tan TZ; Ler SG; Chia KS; Lim WY; Bütow Z; Vordos D; De la Taille A; Al-Haddawi M; Raida M; Beyer B; Ricci E; Colombel M; Chong TW; Chiong E; Soo R; Park MK; Ha HK; Gunaratne J; Thiery JP
Oncotarget; 2015 May; 6(15):13539-49. PubMed ID: 25915536
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
[TBL] [Abstract][Full Text] [Related]
27. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
29. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
[No Abstract] [Full Text] [Related]
30. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
Miyake M; Morizawa Y; Hori S; Tatsumi Y; Onishi S; Owari T; Iida K; Onishi K; Gotoh D; Nakai Y; Anai S; Chihara Y; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K
Cancer Sci; 2017 Nov; 108(11):2221-2228. PubMed ID: 28837258
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
[TBL] [Abstract][Full Text] [Related]
32. A microRNA biomarker panel for the non-invasive detection of bladder cancer.
Urquidi V; Netherton M; Gomes-Giacoia E; Serie DJ; Eckel-Passow J; Rosser CJ; Goodison S
Oncotarget; 2016 Dec; 7(52):86290-86299. PubMed ID: 27863434
[TBL] [Abstract][Full Text] [Related]
33. Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer.
Hirotsu Y; Yokoyama H; Amemiya K; Hagimoto T; Daimon H; Hosaka K; Oyama T; Mochizuki H; Omata M
Cancer Sci; 2019 Oct; 110(10):3235-3243. PubMed ID: 31368627
[TBL] [Abstract][Full Text] [Related]
34. Independent verification of circulating miRNA as diagnostic biomarkers for urothelial carcinoma.
Urabe F; Matsuzaki J; Takeshita F; Kishida T; Ochiya T; Hirai K
Cancer Sci; 2022 Oct; 113(10):3510-3517. PubMed ID: 35848873
[TBL] [Abstract][Full Text] [Related]
35. Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids.
Tsujiura M; Ichikawa D; Konishi H; Komatsu S; Shiozaki A; Otsuji E
World J Gastroenterol; 2014 Mar; 20(12):3265-86. PubMed ID: 24696609
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
37. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
[TBL] [Abstract][Full Text] [Related]
39. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
[TBL] [Abstract][Full Text] [Related]
40. DNA Hypermethylation af a Panel Of Genes as an Urinary Biomarker For Bladder Cancer Diagnosis.
Georgopoulos P; Papaioannou M; Markopoulou S; Fragou A; Kouvatseas G; Apostolidis A
Urol J; 2021 Nov; 19(3):214-220. PubMed ID: 34806159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]